Cefadroxil Capsule / 500 mg / 100 Count
Cefadroxil Capsule
500 mg / 100 CountBack to Products
Brand name: Duricef®
Cefadroxil is indicated for the treatment of patients with infection caused by susceptible strains of the designated organisms in the following diseases:
Urinary tract infections caused by E. coli, P. mirabilis, and Klebsiella species.
Skin and skin structure infections caused by staphylococci and/or streptococci.
Pharyngitis and/or tonsillitis caused by Streptococcus pyogenes (Group A beta-hemolytic streptococci).
For more information please see the prescribing information on DailyMed.
| Product Information | |
|---|---|
| Product Name | Cefadroxil Capsule |
| Strength | 500 mg |
| Strength | 500 mg |
| Dosage Form | Capsule |
| Pack Size | 100 Count |
| NDC | 57237-096-01 |
| OTC/Rx | Rx |
| TE Code | AB |
| Product Characteristics | |
|---|---|
| Color | Maroon/white colored |
| Shape | Capsule |
| Gluten | Free from Gluten |
| Lactose | Free from Lactose |
| Sweeteners | Not Applicable |
| Soy | Free from Soy |
| Gelatin | Contains Gelatin |
| Allergen Info | Free from dairy products and egg products |
| Other Product Info | Not Applicable |
| Other Information | |
|---|---|
| Inactive Ingredients | Lactose monohydrate, magnesium stearate, FD&C Blue no. 1, D&C Red no. 28, FD&C Red no. 40, titanium dioxide, gelatin, sodium lauryl sulfate, ferrosoferric oxide |
| Imprint/Markings | C;97 |
| Special Instructions | Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. |
| Product Shelf Life | 24 months |
*The brand names listed are not owned by Rising Pharma. Rising Pharma products are generic equivalents to the respective brand names listed on this website.
